Online citations, reference lists, and bibliographies.
← Back to Search

Lignin-graft-PLGA Drug-delivery System Improves Efficacy Of MEK1/2 Inhibitor In Triple-negative Breast Cancer Cell Line.

C. Byrne, C. Astete, Manibarathi Vaithiyanathan, A. Melvin, Mahsa Moradipour, S. Rankin, B. L. Knutson, C. Sabliov, E. C. Martin
Published 2020 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Aim: Few targeted therapies are available for triple-negative breast cancer (TNBC) patients. Here, we propose a novel alkaline-lignin-conjugated-poly(lactic-co-glycolic acid) (L-PLGA) nanoparticle drug delivery system to improve the efficacy of targeted therapies. Materials & methods: L-PLGA nanoparticles (NPs) loaded with the MEK1/2 inhibitor GDC-0623 were characterized, tested in vitro on MDA-MB-231 TNBC cell line and compared with loaded PLGA NPs. Results: Loaded L-PLGA NPs were less than half the size of PLGA NPs, had slower drug release and improved the efficacy of GDC-0623 when tested in vitro. We demonstrated that GDC-0623 reversed epithelial-to-mesenchymal transition in TNBC. Conclusion: Our findings indicate that L-PLGA NPs are superior to PLGA NPs in delivering GDC-0623 to cancer cells for improved efficacy in vitro.
This paper references
10.1016/j.molcel.2010.02.020
ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.
Sejeong Shin (2010)
10.1016/j.bbamem.2014.10.019
Real-time examination of aminoglycoside activity towards bacterial mimetic membranes using Quartz Crystal Microbalance with Dissipation monitoring (QCM-D).
Tanmaya Joshi (2015)
10.1016/J.EURPOLYMJ.2017.05.047
Amphiphilic polymer layer – Model cell membrane interaction studied by QCM and AFM
A. Ábrahám (2017)
10.1021/BI982708K
Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex.
X. Wang (1999)
10.1016/j.jconrel.2008.09.074
Drug targeting and tumor heterogeneity.
Y. Bae (2009)
10.1021/acs.jpcb.9b05525
Experimental and Molecular Dynamics Simulation Study of the Effects of Lignin Dimers on the Gel-to-Fluid Phase Transition in DPPC Bilayers.
X. Tong (2019)
10.1021/jf202135j
PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
XiaoXia Xie (2011)
10.1016/J.BIOMATERIALS.2004.07.050
Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
K. Y. Win (2005)
10.1016/j.ijpharm.2016.12.006
Layer-by-layer nanoparticle platform for cancer active targeting.
Min Sung Suh (2017)
10.4161/cc.9.13.12270
ERK2/Fra1/ZEB pathway induces epithelial-to-mesenchymal transition
Sejeong Shin (2010)
10.3390/IJMS9040498
Supported Phospholipid Bilayer Interaction with Components Found in Typical Room-Temperature Ionic Liquids – a QCM-D and AFM Study †
K. Evans (2008)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.1200/JCO.2015.62.1052
Improving Prospects for Targeting RAS.
Harshabad Singh (2015)
10.1016/j.cell.2014.10.032
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
T. S. Gujral (2014)
10.1016/j.colsurfb.2012.06.024
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats.
N. Khalil (2013)
10.1016/j.cell.2009.12.040
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
S. Heidorn (2010)
10.1016/j.ejps.2016.08.061
Towards targeted cancer therapy: Aptamer or oncolytic virus?
Kei Xian Tan (2017)
10.1163/156856206775997322
Synthesis and characterization of PLGA nanoparticles
C. Astete (2006)
10.1016/j.bpc.2015.05.006
Size dependence of gold nanoparticle interactions with a supported lipid bilayer: A QCM-D study.
C. Bailey (2015)
10.3389/fchem.2016.00046
Probing the Interaction between Nanoparticles and Lipid Membranes by Quartz Crystal Microbalance with Dissipation Monitoring
Nariman Yousefi (2016)
10.1097/EDE.0000000000000394
Cardiovascular Disease Mortality Among Breast Cancer Survivors
P. Bradshaw (2016)
10.1016/j.jconrel.2010.08.027
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
10.2174/0929867323666160814002150
New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.
M. Zając (2016)
10.1038/nprot.2010.65
Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates
Nam-Joon Cho (2010)
10.1021/acs.analchem.7b05423
Quantitative Rheometry of Thin Soft Materials Using the Quartz Crystal Microbalance with Dissipation.
Kazi Sadman (2018)
10.1021/la100275v
Quantification of the layer of hydration of a supported lipid bilayer.
Theodore J. Zwang (2010)
10.1016/S0378-5173(01)00923-1
Characterization of nanoparticle uptake by endothelial cells.
J. Davda (2002)
10.1172/JCI57152
Targeted therapies for breast cancer.
M. Higgins (2011)
10.1200/JCO.2015.66.2346
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
D. Hershman (2016)
10.1016/J.TIPS.2004.12.002
Overcoming limitations of natural anticancer drugs by combining with artificial agents.
M. V. Blagosklonny (2005)
10.1158/1535-7163.TARG-13-B75
Abstract B75: A first in-human phase I study to evaluate the MEK1/2 inhibitor GDC-0623 in patients with advanced solid tumors.
A. El-Khoueiry (2013)
10.1042/BST20140129
Intrinsic and acquired resistance to MEK1/2 inhibitors in cancer.
M. J. Sale (2014)
10.1016/j.cis.2015.10.004
QCM-D study of nanoparticle interactions.
Q. Chen (2016)
10.1038/sj.onc.1210915
Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells
S. Uttamsingh (2008)
10.1016/j.ejpb.2008.11.010
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
10.1517/17425247.2011.543673
Potential of polymeric nanoparticles in AIDS treatment and prevention
N. Khalil (2011)
10.1016/j.biomaterials.2009.01.057
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.
Malgorzata S Cartiera (2009)
10.1016/j.msec.2015.11.067
Polymeric nanoparticles for targeted drug delivery system for cancer therapy.
F. Masood (2016)
10.2147/IJN.S26679
The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation
M. Santos-Martinez (2012)
10.1016/j.ctrv.2016.05.001
The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients.
M. O'Rorke (2016)
10.1163/156856202320401951
Acoustics of blood plasma on solid surfaces
M. Andersson (2002)
10.1016/j.ijpharm.2009.03.018
Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
Jie Gao (2009)
10.1016/J.APSUSC.2017.05.255
Magnetite nanoparticles conjugated with lignin: A physicochemical and magnetic study
Łukasz Klapiszewski (2017)
10.1016/j.bios.2008.02.011
Characterization of QCM sensor surfaces coated with molecularly imprinted nanoparticles.
Kristina Reimhult (2008)
10.4236/JBNB.2011.22023
Structural Rearrangements of Polymeric Insulin-loaded Nanoparticles Interacting with Surface-Supported Model Lipid Membranes
R. Frost (2011)
10.1023/B:PHAM.0000022411.47059.76
The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers
Mohamed G. Qaddoumi (2004)
10.1016/S0168-3659(02)00127-X
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
S. Sahoo (2002)
10.1186/s12951-016-0185-x
Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer
L. Sims (2016)
10.1038/NM0195-27
Angiogenesis in cancer, vascular, rheumatoid and other disease
J. Folkman (1995)
10.1021/ja2040305
Disruption of supported lipid bilayers by semihydrophobic nanoparticles.
Benxin Jing (2011)
10.1116/1.4944830
Understanding the formation of supported lipid bilayers via vesicle fusion-A case that exemplifies the need for the complementary method approach (Review).
T. Lind (2016)
10.1016/j.addr.2013.09.001
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
Ameya R. Kirtane (2013)
10.1093/annonc/mdu203
History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis.
C. Chao (2014)
10.1021/LA0610452
Quantitative analysis of tethered vesicle assemblies by quartz crystal microbalance with dissipation monitoring: Binding dynamics and bound water content.
A. Patel (2006)
10.1021/ja309812z
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency.
A. Leśniak (2013)
10.1038/nbt.3330
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.
A. Adeyinka (2002)
10.1038/nature12441
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
G. Hatzivassiliou (2013)
10.1200/JCO.2007.15.7438
Monoclonal antibodies in cancer therapy: 25 years of progress.
R. Oldham (2008)
10.1021/es403864v
Nanoparticles meet cell membranes: probing nonspecific interactions using model membranes.
K. L. Chen (2014)
10.1116/1.4963188
Formation of planar unilamellar phospholipid membranes on oxidized gold substrate.
I. Y. Hasan (2016)
10.1038/nbt.2786
Clinical development success rates for investigational drugs
M. Hay (2014)
10.2147/IJN.S75090
PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway
Wen Bao (2015)
10.1021/la503086a
A biomimetic platform to study the interactions of bioelectroactive molecules with lipid nanodomains.
J. T. Marquês (2014)
10.1677/JME-07-0165
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-α activity
R. Thomas (2008)
10.4155/tde.14.85
Surface association and uptake of poly(lactic-co-glycolic) acid nanoparticles by Aspergillus flavus.
Erica S Muse (2014)
10.1038/emm.2014.99
Activation of KRAS promotes the mesenchymal features of basal-type breast cancer
Rae-Kwon Kim (2015)
10.1038/bjc.1997.507
Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.
M. de Boer-Dennert (1997)
10.1016/j.jconrel.2015.08.041
Cancer targeted therapeutics: From molecules to drug delivery vehicles.
D. Liu (2015)
10.1016/j.colsurfb.2009.09.001
Biodegradable polymeric nanoparticles based drug delivery systems.
A. Kumari (2010)
10.2147/IJN.S32188
A physical model for the size-dependent cellular uptake of nanoparticles modified with cationic surfactants
A. Xu (2012)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
10.1007/s10555-005-6192-2
Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies
A. Iannello (2005)
ras oncogenes in human cancer: a review.
J. Bos (1989)
10.1128/MCB.23.12.4401-4415.2003
Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization
L. Casalino (2003)
10.1001/JAMA.295.14.1658
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
D. Berry (2006)
10.1016/j.msec.2017.03.121
Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells.
Brenda Brenner S. Cerqueira (2017)
10.1039/C6RA05693H
TiO2 nanoparticle interactions with supported lipid membranes – an example of removal of membrane patches
Fang Zhao (2016)
10.1016/J.BBAMCR.2007.01.012
Ras oncogenes and their downstream targets.
K. Rajalingam (2007)
10.1002/JAB.770020205
Poly(vinyl alcohol) hydrogel as an artificial articular cartilage: evaluation of biocompatibility.
T. Noguchi (1991)
10.1021/acs.accounts.7b00477
In Situ Real-Time Mechanical and Morphological Characterization of Electrodes for Electrochemical Energy Storage and Conversion by Electrochemical Quartz Crystal Microbalance with Dissipation Monitoring.
Netanel Shpigel (2018)
10.1074/jbc.M115.657833
The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism*
A. Zaanan (2015)
10.1021/la501534f
Solvent-assisted lipid bilayer formation on silicon dioxide and gold.
S. Tabaei (2014)
10.1021/la803912p
Model-independent analysis of QCM data on colloidal particle adsorption.
Edurne Tellechea (2009)



Semantic Scholar Logo Some data provided by SemanticScholar